Markets:

Overview

News

Currencies

International

Treasuries

Dynavax Technologies Corporation - Common Stock (NQ:DVAX)

15.38 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Dynavax Technologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

Dynavax Technologies (DVAX) Q3 2023 Earnings Call Transcript ↗

November 03, 2023

DVAX earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Earnings Preview For Dynavax Technologies ↗

November 01, 2023

Via Benzinga

Preview: Dynavax Technologies's Earnings ↗

August 02, 2023

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

May 29, 2023

Via Benzinga

The Latest Analyst Ratings for Dynavax Technologies ↗

May 03, 2023

Via Benzinga

Dynavax Technologies's Return On Capital Employed Insights ↗

March 01, 2023

Via Benzinga

Cramer Suggests Buying Fast Food Chain Owner Of Popeye's, Burger King: Here's Why ↗

September 07, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Restaurant Brands International Inc. (NYSE: QSR) is a buy.

Via Benzinga

Dynavax Technologies Stock Sees Renewed Technical Strength ↗

August 07, 2023

Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.

Via Investor's Business Daily

Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗

August 04, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

JMP Securities Maintains Market Outperform Rating for Dynavax Technologies: Here's What You Need To Know ↗

February 24, 2023

Via Benzinga

Dynavax Technologies (DVAX) Q3 2022 Earnings Call Transcript ↗

November 03, 2022

DVAX earnings call for the period ending September 30, 2022.

Via The Motley Fool

Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript ↗

August 04, 2023

DVAX earnings call for the period ending June 30, 2023.

Via The Motley Fool

Overview Of Value Stocks In The Healthcare Sector ↗

July 31, 2023

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

July 24, 2023

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

July 17, 2023

Via Benzinga

The 7 Best Stocks Under $15 to Buy in June 2023 ↗

June 01, 2023

While you generally get what you pay for, these best stocks under $15 for June provide compelling opportunities at discount.

Via InvestorPlace

Dynavax Technologies (DVAX) Q1 2023 Earnings Call Transcript ↗

May 02, 2023

DVAX earnings call for the period ending March 31, 2023.

Via The Motley Fool

7 Biotech Stocks Sitting in the Sweet Spot ↗

March 24, 2023

Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable.

Via InvestorPlace

The Top 7 Growth Stocks in Biotech ↗

March 03, 2023

The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.

Via InvestorPlace

Dynavax Technologies (DVAX) Q4 2022 Earnings Call Transcript ↗

February 23, 2023

DVAX earnings call for the period ending December 31, 2022.

Via The Motley Fool

Jim Cramer On This Stock Up 2% Over 6 Months: 'You've Got A Real Winner There' ↗

January 20, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Weyerhaeuser Co (NYSE: WY) a lot.

Via Benzinga

Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023

January 15, 2023

From Clover Biopharmaceuticals

Via GlobeNewswire

The 7 Most Undervalued Long-Term Stocks to Buy in January ↗

January 14, 2023

Investors should keep an eye on these severely undervalued long-term stocks as we get deeper into New Year 2023.

Via InvestorPlace

Our 7 Top Small-Cap Stock Picks for 2023 ↗

December 12, 2022

Most of the names on this list of small-cap stock picks for 2023 are ready to rebound from a tough year in the markets.

Via InvestorPlace

Dynavax Adjuvant Based COVID-19 Vaccine Lowers The Risk Of Transmission ↗

November 30, 2022

Via Benzinga

Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases

November 30, 2022

From Clover Biopharmaceuticals

Via GlobeNewswire

Earnings Preview For Dynavax Technologies ↗

November 02, 2022

Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

3 Under-the-Radar Small-Cap Stocks With 100% Upside Potential ↗

October 13, 2022

If under-the-radar small-cap stocks are your jam, I’ve got three selections from the S&P SmallCap 600 that might be right up your alley.

Via InvestorPlace

Clover Provides Update on 2022 Corporate Milestones

October 09, 2022

From Clover Biopharmaceuticals

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.